CCM
AGN

Camber Capital Management’s Allergan plc AGN Stock Holding History

Camber Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-500,000
Closed -$84.1M – 39
2019
Q3 		$84.1M Hold
500,000
– – 4.42% 6
2019
Q2 		$83.7M Buy
+500,000
New +$69.2M 3.9% 9
2019
Q1 		– Sell
-1,000,000
Closed -$134M – 39
2018
Q4 		$134M Buy
+1,000,000
New +$164M 6.34% 3

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Camber Capital Management's AGN Position: Q1 2020 in Review

Camber Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,000,000 shares — an estimated $191M sold.

Camber Capital Management first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $209M in Q2 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Camber Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Camber Capital Management sold 1,000,000 Allergan plc shares in Q1 2020, an estimated $191M.
  • Camber Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
  • Camber Capital Management's Allergan plc position peaked at $209M in Q2 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Camber Capital Management's 13F filing for Q1 2020, filed 15 May 2020.